Norway started operating the MF Hydra ferry as the world's first ship running on liquid hydrogen.
According to Erlend Hovland, chief technology officer of Norled, a Norwegian ferry operator, they have conducted a lot of development and testing and are now looking forward to welcoming passengers on board for a zero-emission journey between Hjelmeland and Nesvik.
Norled led the project to develop the technology for MF Hydra, while Linde Engineering of Germany supplied the hydrogen systems on board, and Danish Ballard developed the fuel cells that produce electricity from hydrogen.
The development of new technology was enabled by the Norwegian Public Roads Administration (NPRA).
Norled noted that its pilot project in Hjelmeland is important for global shipping as liquid hydrogen could have a key role in the green maritime transition.


Fertile land for growing vegetables is at risk — but a scientific discovery could turn the tide
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
GesiaPlatform Launches Carbon-Neutral Lifestyle App ‘Net Zero Heroes’
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
How ongoing deforestation is rooted in colonialism and its management practices
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



